Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease

Brain

Volumn 129, Issue 7, 2006, Pages 1748-1757

  Alonso Frech, F ^b   Zamarbide, I ^c   Alegre, M ^a   Rodriguez Oroz M C ^a   Guridi, J ^a   Manrique, M ^a   Valencia, M ^a   Artieda, J ^a   Obeso, J A ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b HOSPITAL UNIVERSITARIO DE FUENLABRADA   (Spain)

^c HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

Author keywords

Dyskinesias; Oscillatory activity; Parkinson's disease; Subthalamic nucleus

Indexed keywords

APOMORPHINE; CARBIDOPA PLUS LEVODOPA; LEVODOPA;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; DRUG EFFECT; DRUG INDUCED DISEASE; DYSKINESIA; ELECTRIC POTENTIAL; ELECTRODE; HUMAN; LEVODOPA INDUCED DYSKINESIA; LOCAL FIELD POTENTIAL; OSCILLATION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SUBTHALAMIC NUCLEUS;

EID: 33745685518     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awl103     Document Type: Article

References (50)

1. Alegre M, Alonso-Frech F, Rodríguez-Oroz MC, Guridi J, Zamarbide I, Valencia M, et al. Movement-related changes in oscillatory activity in the human subthalamic nucleus: ipsilateral versus contralateral movements. Eur J Neurosci 2005; 22: 2315-24.
2. Bevan MD, Magill PJ, Terman D, Bolam JP, Wilson CJ. Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network. Trends Neurosci 2002; 25: 525-31.
3. Boraud T, Bezard E, Bioulac B, Gross C. Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alteration of pallidal neurons in the MPTP-treated monkey. Brain 2001; 124: 546-57.
4. Brown P. Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson's disease. Mov Disord 2003; 18: 357-63.
5. Brown P, Oliviero A, Mazzone P, Insola A, Tonali P, Di Lazzaro V. Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease. J Neurosci 2001; 21: 1033-8.
6. Fahn S. The spectrum of levodopa-induced dyskinesias. Ann Neurol 2000; 47: S2-S11.
7. Foffani G, Priori A, Egidi M, Rampini P, Tamma F, Caputo E, et al. 300-Hz subthalamic oscillations in Parkinson's disease. Brain 2003; 126: 2153-63.
8. Foffani G, Ardolino G, Meda B, Egidi M, Rampini P, Caputo E, et al. Altered subthalamo-pallidal synchronisation in parkinsonian dyskinesias. J Neurol Neurosurg Psychiatry 2005; 76: 426-8.
9. Fogelson N, Pogosyan A, Kuhn AA, Kupsch A, van Bruggen G, Speelman H, et al. Reciprocal interactions between oscillatory activities of different frequencies in the subthalamic region of patients with Parkinson's disease. Eur J Neurosci 2005; 22: 257-66.
10. Gernet M, Richter A, Rundfeldt C, Loscher W. Quantitative EEG analysis of depth electrode recordings from several brain regions of mutant hamsters with paroxysmal dystonia discloses frequency changes in the basal ganglia. Mov Disord 1998; 13: 509-21.
11. Guigoni C, Li Q, Aubert I, Dovero S, Bioulac BH, Bloch B, et al. Involvement of sensorimotor, limbic, and associative basal ganglia domains in l-3.4-dihydroxyphenylalanine-induced dyskinesia. J Neurosci 2005; 23: 2102-7.
12. Guridi J, Gorospe A, Ramos E, Rodríguez MC, Linazasoro G, Obeso JA. Targeting the basal ganglia for pallidotomy in Parkinson's disease. Neurosurgery 1999; 45: 278-87.
13. Heimer G, Bar-Gad I, Goldberg JA, Bergman H. Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism. J Neurosci 2002; 22: 7850-5.
14. Hutchison WD, Allan RJ, Opitz H, Levy R, Dostrovsky JO, Lang AE, et al. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol 1998; 44: 622-8.
15. Kuhn AA, Williams D, Kupsch A, Limousin P, Hariz M, Schneider GH, et al. Event-related beta desynchronization in human subthalamic nucleus correlates with motor performance. Brain 2004; 127: 735-46.
16. Kuhn AA, Trottenberg T, Kivi A, Kupsch A, Schneider G-H, Brown P. The relationship between local field potential and neuronal discharge in the subthalamic nucleus of patients with Parkinson's disease. Exp Neurol 2005; 194: 212-20.
17. Lang AE. Surgery for levodopa-induced dyskinesias. Ann Neurol 2000; 47: S193-200.
18. Lenz F, Suarez JL, Metman LV, Reich SG, Karp BI, Hallett M, et al. Pallidal activity during dystonia: somatosensory reorganisation and changes with severity. J Neurol Neurosurg Psychiatry 1998; 65: 767-70.
19. Levy R, Hutchinson WD, Lozano AM, Dostrovsky JO. High-frequency synchronization of neuronal activity in the subthalamic nucleus of parkinsonian patients with limb tremor. J Neurosci 2000; 20: 7766-75.
20. Levy R, Dostrovsky JO, Lang AE, Sime E, Hutchison WD, Lozano AM. Effects of apomorphine on subthalamic nucleus and globus pallidus pars interna neurons in patients with Parkinson's disease. J Neurophysiol 2001; 86: 249-60.
21. Levy R, Hutchinson WD, Lozano AM, Dostrovsky JO. Synchronized neuronal discharge in the basal ganglia of parkinsonian patients is limited to oscillatory activity. J Neurosci 2002; 22: 2855-61.
22. Liu X, Ford-Dunn HL, Hayward GN, Nandi D, Miall RC, Aziz TZ, et al. The oscillatory activity in the parkinsonian subthalamic nucleus investigated using the macro-electrodes for deep brain stimulation. Clin Neurophysiol 2002; 113: 1667-72.
23. Lozano AM, Lang AE, Levy R, Hutchison W, Dostrovsky J. Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine. Ann Neurol 2000; 47: S141-6.
24. Luquin MR, Scipioni O, Vaamonde J, Gershanik O, Obeso JA. Levodopa-induced dyskinesias in Parkinson's disease. Clinical and pharmacological classification. Mov Disord 1992; 7: 117-24.
25. Manson AJ, Brown P, O'Sullivan JD, Asselman P, Buckwell D, Lees AJ. An ambulatory dyskinesia monitor. J Neurol Neurosurg Psychiatry 2000; 68: 196-201.
26. Marconi R, Lefebvre-Caparros D, Bonnet AM, Vidailhet M, Dubois B, Agid Y. Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology. Mov Disord 1994; 9: 2-12.
27. Marsden CD, Obeso JA. The enigma of stereotaxic surgery for Parkinson's disease leading to a dual hypothesis of basal ganglia function. Brain 1994; 117: 887-97.
28. Meissner W, Ravenscroft P, Reese R, Harnack D, Morgenstern R, Kupsch A, et al. Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracelullar striatal dopamine. Neurobiol Dis 2006. [Epub ahead of print].
29. Merello M, Balej J, Delfino M, Cammarota A, Betti O, Leiguarda R. Apomorphine induces changes in GPi spontaneous outflow in patients with Parkinson's disease. Mov Disord 1999; 14: 45-9.
30. Mitchell IJ, Boyce S, SambrookMA, Crossman AR. A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesias. Brain 1992; 115: 808-24.
31. Muenter MD, Tyce GM. L-dopa therapy of Parkinson's disease: plasma L-dopa concentrations, therapeutic response, and side effects. Mayo Clinic Proc 1971; 46: 231-9.
32. Obeso JA, Rodriguez-Oroz MC, Rodriguez M, DeLong MR, Olanow W. Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model. Ann Neurol 2000; 47: S22-34.
33. Obeso JA, Olanow CW, Rodriguez-Oroz MC, Crack P, Kumar R, Lang AE. (The Deep Brain Stimulation for Parkinson's Disease Study Group). Deep brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001; 345: 956-63.
34. Obeso JA, Rodriguez-Oroz MC, Marin C, Alonso F, Zamarbide I, Lanciego JL. et al. The origin of motor fluctuations in Parkinson's disease: importance of dopaminergic innervation and basal ganglia circuits. Neurology 2004; 62: S17-30.
35. Papa SM, Desimone R, Fiorani M, Oldfield EH. Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias. Ann Neurol 1999; 46: 732-8.
36. Priori A, Foffani G, Pesenti A, Tamma F, Bianchi AM, Pellegrini M, et al. Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease. Exp Neurol 2004; 189: 369-79.
37. Raz A, Vaadia E, Bergman H. Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. J Neurosci 2000; 20: 8559-71.
38. Rodriguez MC, Guridi J, Alvarez L, Mewes K, Macias R, Vitek J, et al. The subthalamic nucleus and tremor in Parkinson's disease. Mov Disord 1998; 13 Suppl 3: 111-8.
39. Rodriguez-Oroz MC, Rodriguez M, Guridi J, Mewis K, Chockkman VJ, Vitek J, et al. The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain 2001; 124: 1777-90.
40. Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto J-L, Pollak P, Rehncrona S, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 2005; 128: 2240-9.
41. Schrag A, Quinn N. Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study. Brain 2000; 123: 2297-305.
42. Silberstein P, Kuhn AA, Kupsch A, Trottenberg T, Krauss JK, Wohrle JC. et al. Patterning of globus pallidus local field potentials differs between Parkinson's disease and dystonia. Brain 2003; 126: 2597-608.
43. Suarez JI, Metman LV, Reich SG, Dougherty PM, Hallett M, Lenz FA. Pallidotomy for hemiballismus: efficacy and characteristics of neuronal activity. Ann Neurol 1997; 42: 807-11.
44. Stefani A, Bassi A, Mazzone P, Pierantozzi M, Gattoni G, Altibrandi MG, et al. Subdyskinetic apomorphine responses in globus pallidus and subthalamus of parkinsonian patients: lack of clear evidence for the 'indirect pathway'. Clin Neurophysiol 2002; 113: 91-100.
45. Suarez JI, Metman LV, Reich SG, Dougherty PM, Hallett M, Lenz FA. Pallidotomy for hemiballismus: efficacy and characteristics of neuronal activity. Ann Neurol 1997; 42: 807-11.
46. Vaamonde J, Luquin MR, Obeso JA. Subcutaneous lisuride infusion in Parkinson's disease: response to chronic administration in 34 patients. Brain 1991; 114: 601-14.
47. Vitek JL, Giroux M. Physiology of hypokinetic and hyperkinetic movement disorders: model for dyskinesia. Ann Neurol 2000; 47: S131-40.
48. Wichmann T, Bergman H, DeLong MR. The primate subthalamic nucleus. I. Functional properties in intact animals. J Neurophyisiol 1994; 72: 521-30.
49. Williams D, Tijssen M, Van Bruggen G, Bosch A, Insola A, Di Lazzaro V, et al. Dopamine-dependent changes in the functional connectivity between basal ganglia and cerebral cortex in humans. Brain 2002; 125: 1558-69.
50. Williams D, Kuhn A, Kupsch A, Tijssen M, Van Bruggen G, Speelman H, et al. The relationship between oscillatory activity and motor reaction time in the parkinsonian subthalamic nucleus. Eur J Neurosci 2005; 21: 249-58.